The resident of the city of Abha, Radwan Ali Jokhbi, begins his day by browsing “Okaz”, due to the diversity of its topics, and the transmission of events from everywhere, including his country, Yemen, and the useful and interesting topics, reports and investigations it contains, as it is committed to credibility and accuracy in all aspects.
Read next
Clinical Trials Accelerate Adoption of Synthetic Control Arms
Pharmaceutical developers are leveraging historical patient datasets to construct synthetic control groups, reducing trial execution timelines and patient…
GLP-1 Supply Stabilization Shifts Focus to Oral Delivery Formulations
Pharmaceutical manufacturers expand Phase III clinical trials for oral obesity therapies as injectable capacity bottlenecks ease.
Creating Wealth Using Legislation Of Attraction
You become thinking, “Alexis, I’ll never see life on my terms until I hit the sweepstakes.. or get…
GLP-1 Class Therapies Reshape Pharmaceutical Market Valuations and R&D
Surging demand for metabolic treatments triggers extensive clinical pipeline reallocations across global pharmaceutical giants.
GLP-1 Class Drugs Expand into Cardiovascular and Metabolic Therapies
Clinical trial outcomes prompt pharmaceutical re-allocation toward broader systemic disease management.
Expansion of GLP-1 Therapies Alters Commercial Healthcare Models
Pharmaceutical advancements in metabolic medicine create new budget considerations for enterprise healthcare plans.